FDA Investigator Nicholas Obiri, PhD

Nicholas Obiri, PhD has inspections in 2 countries as of 14 Sep 2023. Nicholas Obiri, PhD has collaborated with a combinined 3890 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
6
Last Inspection Date:
14 Sep 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America, United Kingdom of Great Britain and Northern Ireland
Co-Investigator(s):
Adaliz Santaliz Cruz, Aikaterini Alexaki, Alan A Rivera, Amalia C Himaya, Amalia Himaya, Andrea A Branche, Andrea George, PhD, Angel K Sandhu, Angela K Shen, Anh M Lac, Anissa M Cheung, Anita Narula, PhD, Arlene M Badillo, Ashley N Queen, PhD, Barbara J Wilcox, PhD, Barry Cherney, PhD, Bichsa T Nguyen, Bichsa T Tran, Bo Chi, PhD, Brien C Fox, Burnell M Henry, Calvin B Koerner, Carl Lee, Carla J Lundi, Carole L Jones, Caryn M Everly, Caryn M Mcnab, Cassandra Overking, Chava Kimchi Sarfaty, PhD, Cheron M Portee, Christina V Santos, Christopher Downey, PhD, Christopher R Czajka, Colleen Thomas, PhD, Cynthia Jim, CSO, Daniel J Roberts, Daniel W Cline, David S Cho, PhD, Davinna Ligons, PhD, Dennis Cantellops Paite, Diane Cvan Leeuwen, Doan T Nguyen, PharmD, Donald C Obenhuber, PhD, Donna Ltartaglino Besone, Dov Pluznik, PhD, Dr. Mark J Seaton, PhD, Dr. Ralph M Bernstein, PhD, Dustin R Abaonza, Eileen A Liu, Eliezar Ramos, Emily Shacter, Eric L Dong, BS, Erika V Butler, Frances Namuswe, PhD, Gene D Arcy, Gerald Feldman, Gerald M Feldman, PhD, Haley H Seymour, Haley Seymour, Haroon Vohra (NMI), Hasan A Irier, PhD, Henry K Lau, Henry X Lau, Iris C Macinnes, Ivis Lnegron Torres, J David Doleski, Jacqueline Mdiaz Albertini, James R Evans, James R Fleckenstein, Jeanne Fringer, PhD, Jee Chung, PhD, Jeffrey M Watson, Jeffrey P Raimondi, Jennifer Gogley, Jennifer Lalama, Jennifer M Gogley, Jerri Baker, Joan A Loreng, Joan T Briones, Joel Welch, PhD, John D Finkbohner, PhD, John M Mcinnis, John R Myung, Jorge L Lajara, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose R Lopez, Jose Velez, Joseph Kutze, PhD, Joseph P Iser, MD, Joshua S Hunt, Joyce A Rockwell, Jun Park, PhD, Ka L Wong, Kathleen R Jones, PhD, Kelvin Cheung, Kelvin X Sanders, Kendra A Biddick, Kevin P Foley, Kim Lthomas Cruse, Lakisha M Williams, Lance M De Souza, MBA, Laura Fontan, MS, Laurie P Norwood, LCDR Jennifer H Rhyu, Leonard H Lavi, Lewis K Antwi, Libia M Lugo, Linda Thai, Linh Tu, LT Rafael Gonzalez, Mabel M Lee, Maida Henesian (NMI), Marcia Britt Williams, Marcus F Yambot, Maria Gutierrez Lugo, PhD, Marian E Ramirez, Marie K Kinkade, Marion Michaelis, Mariza M Jafary, Mark A Elengold, Marsha W Major, Maxwell Van Tassell, PhD, Maxyne T Lam, Michael A Charles, Michael Shanks, MS, Michele L Forster, PhD, Michelle A Marsh, Michelle Rfrazier Jessen, PhD, Michelle Y Clark Stuart, Mihaly S Ligmond, Milva E Melendez, Milva Emelendez Perales, Min Shanma Liu, Mohsen Rajabi Abhari, FDA, Myriam M Sosa, Natalya M Ananyeva, Nayan J Patel, Nayan Patel, Nicola M Fenty Stewart, Nikolay Spiridonov, Noreen Muniz, Noreen Muñiz, Nydia E Colon, Omatunde O Osunsamni, Omotunde O Osunsanmi, Patricia Fhughes Troost, Paul Z Balcer, Paula A Trost, Peter E Baker, Peter Kessler, PhD, Peter S Diak, Prabhu P Raju, Ramesh Potla, PhD, Ramon A Hernandez, Raymond T Oji, Rebecca E Dombrowski, Rebecca K Olin, Rebecca Parrilla, Rebecca Rodriguez, Rebecca T Davis, Richmond K Yip, Riley C Myers, PhD, Robert D Tollefsen, Robert Darius, Robert W Jennings, Robin Levis, PhD, Roger F Zabinski, Roman Drews, PhD, Ronald L Koller, Ronda Lebland, Rose Ashley, Rose M Ashley, Sandra S Saniga, Sarah Arden, Scott N Lim, Scott R Nichols, PhD, Serge Beaucage, Shelley H Beausoleil, Sherri J Jackson, Sidney B Priesmeyer, Simone E Pitts, Sonia R Peterson, Stanley Au, Stephanie A Slater, MS, Steven A Rubin, Steven C Madzo, Steven Fong, MS, PhD, Stuart W Russell, Susan F Laska, MS, Susan M Jackson, Susan Yu, Svetlana A Shestopal, Taichun Qin, PhD, Terri L Dodds, Thao T Kwan, Thao Tran, Thao X Tran, Thea C Grome, Thomas J Arista, Thuy T Nguyen, LCDR, Timothy C Grome, Timothy Wadkin, PhD, Truong Xuan Nguyen (Andy), Uttaniti Limchumroon (Tom), Vilmary Negron Rodriguez, Wendy G Tan, PhD, William V Millar, Yi Wang, PhD, Yumi J Hiramine, Yvonne C Wilkes, Zachary L Stamm, Zhihao Qiu (Peter), PhD, Zhong Li, PhD

Nicholas Obiri, PhD's Documents

Publish Date Document Type Title
October, 2000 FDA 483 Amgen, Inc - Form 483, 2000-10-20
January, 2000 EIR Genentech, Inc. - EIR, 2000-01-14
May, 2001 FDA 483 Response Seqirus Vaccines Limited - Form 483R, 2001-05-31
July, 2001 EIR BAXALTA US INC. - EIR, 2001-07-13
May, 2001 FDA 483 Evans Vaccines Ltd. - Form 483, 2001-05-11
January, 2000 FDA 483 Genentech, Inc. - Form 483, 2000-01-14
October, 2000 EIR Amgen Manufacturing Ltd - EIR, 2000-10-20
May, 2001 EIR Seqirus Vaccines Limited - EIR, 2001-05-11

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more